HEADER HYDROLASE 12-APR-05 2BOK
TITLE FACTOR XA - CATION
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: COAGULATION FACTOR X;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 234-475;
COMPND 5 SYNONYM: FACTOR XA, STUART FACTOR;
COMPND 6 EC: 3.4.21.6;
COMPND 7 ENGINEERED: YES;
COMPND 8 MUTATION: YES;
COMPND 9 MOL_ID: 2;
COMPND 10 MOLECULE: COAGULATION FACTOR X;
COMPND 11 CHAIN: L;
COMPND 12 FRAGMENT: EGF2 DOMAIN, RESIDUES 126-180;
COMPND 13 SYNONYM: FACTOR XA, STUART FACTOR;
COMPND 14 EC: 3.4.21.6;
COMPND 15 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 7 MOL_ID: 2;
SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 9 ORGANISM_COMMON: HUMAN;
SOURCE 10 ORGANISM_TAXID: 9606;
SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS SERINE PROTEASE, COAGULATION FACTOR, CATION, INHIBITOR, EGF- LIKE
KEYWDS 2 DOMAIN, HYDROLASE, PLASMA, PROTEASE
EXPDTA X-RAY DIFFRACTION
AUTHOR M.MORGENTHALER,K.SCHAERER,R.PAULINI,U.OBST-SANDER,D.W.BANNER,
AUTHOR 2 D.SCHLATTER,J.BENZ,M.STIHLE,F.DIEDERICH
REVDAT 7 06-NOV-24 2BOK 1 REMARK
REVDAT 6 13-DEC-23 2BOK 1 LINK
REVDAT 5 05-JUL-17 2BOK 1 REMARK
REVDAT 4 24-FEB-09 2BOK 1 VERSN
REVDAT 3 25-JUL-05 2BOK 1 JRNL
REVDAT 2 07-JUL-05 2BOK 1 SEQRES
REVDAT 1 16-JUN-05 2BOK 0
JRNL AUTH K.SCHARER,M.MORGENTHALER,R.PAULINI,U.OBST-SANDER,D.W.BANNER,
JRNL AUTH 2 D.SCHLATTER,J.BENZ,M.STIHLE,F.DIEDERICH
JRNL TITL QUANTIFICATION OF CATION-PI INTERACTIONS IN PROTEIN-LIGAND
JRNL TITL 2 COMPLEXES: CRYSTAL-STRUCTURE ANALYSIS OF FACTOR XA BOUND TO
JRNL TITL 3 A QUATERNARY AMMONIUM ION LIGAND
JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 44 4400 2005
JRNL REFN ISSN 1433-7851
JRNL PMID 15952226
JRNL DOI 10.1002/ANIE.200500883
REMARK 2
REMARK 2 RESOLUTION. 1.64 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.2.0005
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.64
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 51.03
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9
REMARK 3 NUMBER OF REFLECTIONS : 30011
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.206
REMARK 3 R VALUE (WORKING SET) : 0.204
REMARK 3 FREE R VALUE : 0.237
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 1607
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.64
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.68
REMARK 3 REFLECTION IN BIN (WORKING SET) : 2169
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : 0.2860
REMARK 3 BIN FREE R VALUE SET COUNT : 112
REMARK 3 BIN FREE R VALUE : 0.2970
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2115
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 30
REMARK 3 SOLVENT ATOMS : 276
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.17
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -1.12000
REMARK 3 B22 (A**2) : 0.19000
REMARK 3 B33 (A**2) : 0.93000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.118
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.113
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.084
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.498
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2200 ; 0.010 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2972 ; 1.251 ; 1.966
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 267 ; 5.789 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 96 ;31.945 ;23.854
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 375 ;11.935 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;13.981 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 323 ; 0.086 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1644 ; 0.004 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 921 ; 0.186 ; 0.200
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1481 ; 0.298 ; 0.200
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 181 ; 0.130 ; 0.200
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 44 ; 0.153 ; 0.200
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 22 ; 0.148 ; 0.200
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1379 ; 0.683 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2149 ; 1.105 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 937 ; 1.512 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 823 ; 2.322 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS.
REMARK 4
REMARK 4 2BOK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-APR-05.
REMARK 100 THE DEPOSITION ID IS D_1290023610.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 14-DEC-04
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : 5.50
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR591
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54182
REMARK 200 MONOCHROMATOR : OSMIC MIRRORS
REMARK 200 OPTICS : OSMIC MIRRORS
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XDS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32725
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.620
REMARK 200 RESOLUTION RANGE LOW (A) : 20.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7
REMARK 200 DATA REDUNDANCY : 5.000
REMARK 200 R MERGE (I) : 0.06000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.62
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.71
REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1
REMARK 200 DATA REDUNDANCY IN SHELL : 4.77
REMARK 200 R MERGE FOR SHELL (I) : 0.37000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.330
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP V. 1
REMARK 200 STARTING MODEL: PDB ENTRY 1C5M
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 34.00
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.88
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.50
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.42000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.37500
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.83500
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 36.37500
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.42000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.83500
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PQS
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, L
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400
REMARK 400 COMPOUND
REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ARG 372 TO GLU
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 ASP A 70
REMARK 465 ARG A 71
REMARK 465 ASN A 72
REMARK 465 THR A 73
REMARK 465 GLU A 74
REMARK 465 GLN A 75
REMARK 465 GLU A 76
REMARK 465 GLU A 77
REMARK 465 GLY A 78
REMARK 465 GLY A 79
REMARK 465 GLU A 80
REMARK 465 ARG A 245
REMARK 465 GLY A 246
REMARK 465 LEU A 247
REMARK 465 PRO A 248
REMARK 465 LYS A 249
REMARK 465 ALA A 250
REMARK 465 LYS A 251
REMARK 465 ARG L 86
REMARK 465 GLU L 103
REMARK 465 GLN L 104
REMARK 465 ARG L 139
REMARK 465 ARG L 140
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 THR A 244 CA C O CB OG1 CG2
REMARK 470 GLU L 138 CA C O CB CG CD OE1
REMARK 470 GLU L 138 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 OD1 ASP A 24 ND2 ASN A 117 2.17
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LYS A 243 -142.93 55.81
REMARK 500 GLN L 98 -114.40 -125.96
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH A2031 DISTANCE = 5.89 ANGSTROMS
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 NA A1245 NA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASP A 185A O
REMARK 620 2 TYR A 185 O 80.9
REMARK 620 3 ARG A 222 O 93.9 174.5
REMARK 620 4 LYS A 224 O 124.8 89.6 91.8
REMARK 620 5 HOH A2170 O 89.4 92.0 89.9 145.5
REMARK 620 N 1 2 3 4
REMARK 700
REMARK 700 SHEET
REMARK 700 DETERMINATION METHOD: DSSP
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A1245
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 784 A1244
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1C5M RELATED DB: PDB
REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING,
REMARK 900 SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
REMARK 900 RELATED ID: 1EZQ RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH
REMARK 900 RPR128515
REMARK 900 RELATED ID: 1F0R RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH
REMARK 900 RPR208815
REMARK 900 RELATED ID: 1F0S RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH
REMARK 900 RPR208707
REMARK 900 RELATED ID: 1FAX RELATED DB: PDB
REMARK 900 COAGULATION FACTOR XA INHIBITOR COMPLEX
REMARK 900 RELATED ID: 1FJS RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED
REMARK 900 WITH FACTOR XA
REMARK 900 RELATED ID: 1FXY RELATED DB: PDB
REMARK 900 COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG-
REMARK 900 CHLOROMETHYLKETONE
REMARK 900 RELATED ID: 1G2L RELATED DB: PDB
REMARK 900 FACTOR XA INHIBITOR COMPLEX
REMARK 900 RELATED ID: 1G2M RELATED DB: PDB
REMARK 900 FACTOR XA INHIBITOR COMPLEX
REMARK 900 RELATED ID: 1HCG RELATED DB: PDB
REMARK 900 BLOOD COAGULATION FACTOR XA
REMARK 900 RELATED ID: 1IOE RELATED DB: PDB
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532
REMARK 900 RELATED ID: 1IQE RELATED DB: PDB
REMARK 900 HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590
REMARK 900 RELATED ID: 1IQF RELATED DB: PDB
REMARK 900 HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165
REMARK 900 RELATED ID: 1IQG RELATED DB: PDB
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159
REMARK 900 RELATED ID: 1IQH RELATED DB: PDB
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143
REMARK 900 RELATED ID: 1IQI RELATED DB: PDB
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125
REMARK 900 RELATED ID: 1IQJ RELATED DB: PDB
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124
REMARK 900 RELATED ID: 1IQK RELATED DB: PDB
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113
REMARK 900 RELATED ID: 1IQL RELATED DB: PDB
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476
REMARK 900 RELATED ID: 1IQM RELATED DB: PDB
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471
REMARK 900 RELATED ID: 1IQN RELATED DB: PDB
REMARK 900 HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192
REMARK 900 RELATED ID: 1KSN RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH
REMARK 900 FXV673
REMARK 900 RELATED ID: 1KYE RELATED DB: PDB
REMARK 900 FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-
REMARK 900 CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE
REMARK 900 RELATED ID: 1LPG RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79.
REMARK 900 RELATED ID: 1LPK RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125.
REMARK 900 RELATED ID: 1LPZ RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41.
REMARK 900 RELATED ID: 1LQD RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45.
REMARK 900 RELATED ID: 1MQ5 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)
REMARK 900 AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2-
REMARK 900 THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA
REMARK 900 RELATED ID: 1MQ6 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-
REMARK 900 PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2-
REMARK 900 OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH
REMARK 900 HUMAN FACTOR XA
REMARK 900 RELATED ID: 1MSX RELATED DB: PDB
REMARK 900 HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-
REMARK 900 METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-
REMARK 900 4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR
REMARK 900 AND MD SIMULATIONS.
REMARK 900 RELATED ID: 1NFU RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH
REMARK 900 RPR132747
REMARK 900 RELATED ID: 1NFW RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH
REMARK 900 RPR209685
REMARK 900 RELATED ID: 1NFX RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH
REMARK 900 RPR208944
REMARK 900 RELATED ID: 1NFY RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH
REMARK 900 RPR200095
REMARK 900 RELATED ID: 1NL8 RELATED DB: PDB
REMARK 900 THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX
REMARK 900 RELATED ID: 1P0S RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH
REMARK 900 ECOTIN M84R
REMARK 900 RELATED ID: 1V3X RELATED DB: PDB
REMARK 900 FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-
REMARK 900 TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-
REMARK 900 CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE
REMARK 900 RELATED ID: 1XKA RELATED DB: PDB
REMARK 900 FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-
REMARK 900 AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID
REMARK 900 RELATED ID: 1XKB RELATED DB: PDB
REMARK 900 FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-
REMARK 900 AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID
REMARK 900 RELATED ID: 2BMG RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50
REMARK 900 RELATED ID: 2BOH RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1
DBREF 2BOK A 16 251 UNP P00742 FA10_HUMAN 235 475
DBREF 2BOK L 86 140 UNP P00742 FA10_HUMAN 126 180
SEQADV 2BOK GLU A 150 UNP P00742 ARG 372 ENGINEERED MUTATION
SEQRES 1 A 241 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO
SEQRES 2 A 241 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE
SEQRES 3 A 241 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR
SEQRES 4 A 241 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL
SEQRES 5 A 241 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY
SEQRES 6 A 241 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN
SEQRES 7 A 241 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL
SEQRES 8 A 241 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL
SEQRES 9 A 241 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER
SEQRES 10 A 241 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE
SEQRES 11 A 241 GLY ARG THR HIS GLU LYS GLY GLU GLN SER THR ARG LEU
SEQRES 12 A 241 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS
SEQRES 13 A 241 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE
SEQRES 14 A 241 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN
SEQRES 15 A 241 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP
SEQRES 16 A 241 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY
SEQRES 17 A 241 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL
SEQRES 18 A 241 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR
SEQRES 19 A 241 ARG GLY LEU PRO LYS ALA LYS
SEQRES 1 L 55 ARG LYS LEU CYS SER LEU ASP ASN GLY ASP CYS ASP GLN
SEQRES 2 L 55 PHE CYS HIS GLU GLU GLN ASN SER VAL VAL CYS SER CYS
SEQRES 3 L 55 ALA ARG GLY TYR THR LEU ALA ASP ASN GLY LYS ALA CYS
SEQRES 4 L 55 ILE PRO THR GLY PRO TYR PRO CYS GLY LYS GLN THR LEU
SEQRES 5 L 55 GLU ARG ARG
HET 784 A1244 29
HET NA A1245 1
HETNAM 784 [AMINO (4-{(3AS,4R,8AS,8BR)-1,3-DIOXO-2- [3-
HETNAM 2 784 (TRIMETHYLAMMONIO) PROPYL]DECAHYDROPYRROLO[3,4-A]
HETNAM 3 784 PYRROLIZIN-4-YL}PHENYL) METHYLENE]AMMONIUM
HETNAM NA SODIUM ION
FORMUL 3 784 C22 H32 N5 O2 1+
FORMUL 4 NA NA 1+
FORMUL 5 HOH *276(H2 O)
HELIX 1 1 ALA A 55 GLN A 61 5 7
HELIX 2 2 GLU A 124A LEU A 131A 1 9
HELIX 3 3 ASP A 164 SER A 172 1 9
HELIX 4 4 PHE A 234 LYS A 243 1 10
HELIX 5 5 LEU L 91 CYS L 96 5 6
SHEET 1 AA 9 GLN A 20 GLU A 21 0
SHEET 2 AA 9 LYS A 156 VAL A 163 -1 O MET A 157 N GLN A 20
SHEET 3 AA 9 MET A 180 ALA A 183 -1 O CYS A 182 N VAL A 163
SHEET 4 AA 9 GLY A 226 LYS A 230 -1 O GLY A 226 N ALA A 183
SHEET 5 AA 9 THR A 206 TRP A 215 -1 O ILE A 212 N THR A 229
SHEET 6 AA 9 PRO A 198 PHE A 203 -1 O HIS A 199 N THR A 210
SHEET 7 AA 9 THR A 135 GLY A 140 -1 O ILE A 137 N VAL A 200
SHEET 8 AA 9 LYS A 156 VAL A 163 1 O LYS A 156 N GLY A 140
SHEET 9 AA 9 GLN A 20 GLU A 21 -1 O GLN A 20 N MET A 157
SHEET 1 AB 7 VAL A 82 HIS A 83 0
SHEET 2 AB 7 LYS A 65 VAL A 68 -1 O VAL A 66 N HIS A 83
SHEET 3 AB 7 GLN A 30 ILE A 34 -1 O LEU A 32 N ARG A 67
SHEET 4 AB 7 GLY A 40 ILE A 46 -1 N PHE A 41 O LEU A 33
SHEET 5 AB 7 TYR A 51 THR A 54 -1 O LEU A 53 N THR A 45
SHEET 6 AB 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54
SHEET 7 AB 7 VAL A 85 LYS A 90 -1 N GLU A 86 O ARG A 107
SHEET 1 LA 2 PHE L 99 HIS L 101 0
SHEET 2 LA 2 VAL L 108 SER L 110 -1 O VAL L 108 N HIS L 101
SHEET 1 LB 2 TYR L 115 LEU L 117 0
SHEET 2 LB 2 CYS L 124 PRO L 126 -1 O ILE L 125 N THR L 116
SSBOND 1 CYS A 22 CYS A 27 1555 1555 2.05
SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.03
SSBOND 3 CYS A 122 CYS L 132 1555 1555 2.05
SSBOND 4 CYS A 168 CYS A 182 1555 1555 1.99
SSBOND 5 CYS A 191 CYS A 220 1555 1555 2.08
SSBOND 6 CYS L 89 CYS L 100 1555 1555 2.03
SSBOND 7 CYS L 96 CYS L 109 1555 1555 2.03
SSBOND 8 CYS L 111 CYS L 124 1555 1555 2.05
LINK O ASP A 185A NA NA A1245 1555 1555 2.57
LINK O TYR A 185 NA NA A1245 1555 1555 2.26
LINK O ARG A 222 NA NA A1245 1555 1555 2.26
LINK O LYS A 224 NA NA A1245 1555 1555 2.25
LINK NA NA A1245 O HOH A2170 1555 1555 2.36
SITE 1 AC1 5 TYR A 185 ASP A 185A ARG A 222 LYS A 224
SITE 2 AC1 5 HOH A2170
SITE 1 AC2 17 GLN A 61 GLU A 97 TYR A 99 PHE A 174
SITE 2 AC2 17 ASP A 189 ALA A 190 GLN A 192 SER A 195
SITE 3 AC2 17 SER A 214 TRP A 215 GLY A 216 GLY A 218
SITE 4 AC2 17 CYS A 220 HOH A2190 HOH A2201 HOH A2212
SITE 5 AC2 17 HOH A2213
CRYST1 48.840 71.670 72.750 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.020475 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013953 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013746 0.00000